DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
7.09
+0.08 (1.14%)
Jul 21, 2026, 1:34 PM EDT - Market open
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $382.03 million as of July 21, 2026. Its market cap has increased by 123.80% in one year.
Market Cap
382.03M
Enterprise Value
327.95M
1-Year Change
123.80%
Ranking
Category
Stock Price
$7.09
ChartMarket Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $382.03M, an increase of 940.96%. That is a compound annual growth rate of 36.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 393.30M | -5.11% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 408.02M |
| C4 Therapeutics | 407.99M |
| Century Therapeutics | 405.80M |
| Enanta Pharmaceuticals | 399.54M |
| Abeona Therapeutics | 398.97M |
| Sutro Biopharma | 390.57M |
| Atea Pharmaceuticals | 389.73M |
| Larimar Therapeutics | 386.22M |